Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 7:39 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 125 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Hospital Admission Clear all

Conditions: Apparent Life Threatening Event, Gastroesophageal Reflux, Aspiration
Interventions: Rice cereal, Enfamil AR; Dietary Supplement
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 0 Years to 1 Year
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hospitalism
Interventions: Our Care Wishes; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 99 Years
Enrollment: 16,020 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Mental Health
Interventions: BH-VPN; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 637 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 6
States / cities: Charlotte, North Carolina • Huntersville, North Carolina • Monroe, North Carolina

Conditions: Utilization of Software Application Features
Interventions: Reminders; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: Not listed
Enrollment: 14,122 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Labor Pain, Early Labor
Interventions: Morphine Sulfate and Promethazine; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Food Insecurity
Interventions: Community Rx-Hunger (CRx-H); Other
Lead sponsor: University of Chicago; Other
Eligibility: Not listed
Enrollment: 660 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: COPD
Interventions: Not listed
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Clostridium Difficile Infection
Interventions: Standard Practice to Prevent Hospital Onset CDI; Other
Lead sponsor: Endeavor Health; Other
Eligibility: Up to 1 Year
Enrollment: 148,549 participants
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Sleep Apnea, Heart Failure
Interventions: Adaptive Servo Ventilation; Device
Lead sponsor: Toronto Rehabilitation Institute; Other
Eligibility: 18 Years and older
Enrollment: 732 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2022
U.S. locations: 3
States / cities: Tucson, Arizona • Kalispell, Montana • Cleveland, Ohio

Conditions: Suicide, Attempted
Interventions: Post Admission Cognitive Therapy (PACT); Behavioral
Lead sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 2
States / cities: Bethesda, Maryland

Conditions: Anemia
Interventions: Drawing admission labs from cord blood, Drawing admission labs from infant blood; Procedure
Lead sponsor: Capt Alicia Prescott; Federal
Eligibility: Up to 1 Day
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 6
States / cities: Honolulu, Hawaii • Bethesda, Maryland • Fort Hood, Texas + 3 more

Conditions: Sickle-Cell Disease With Crisis
Interventions: sublingual sufentanil; Drug
Lead sponsor: Jason Wilson; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Hypoglycemia, Neonatal Hypoglycemia
Interventions: Not listed
Lead sponsor: Pediatrix; Other
Eligibility: 34 Weeks and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Pulmonary Disease, Chronic Obstructive, Pulmonary Diseases, Obstructive
Interventions: Automatic inclusion of COPD orders in admission orders, Dynamic, end-user order set design; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 310 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Community Reinforcement And Family Training, Family Health, Substance-Related Disorders
Interventions: Digital Tutorial overview, Digital Tutorial plus training Materials, Digital Tutorial plus training Materials plus feedback and Coaching; Behavioral
Lead sponsor: We The Village, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Gram-negative Bacterial Infection
Interventions: Part A: ATM-AVI Single Dose, Cohorts 1-4, Part B: Multiple-dose ATM-AVI, Cohorts 1-4; Drug
Lead sponsor: Pfizer; Industry
Eligibility: Up to 39 Weeks
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 11
States / cities: Orange, California • Aurora, Colorado • Indianapolis, Indiana + 4 more

Conditions: Pancreatitis
Interventions: Early cholecystectomy with IOC, Late cholecystectomy with IOC; Procedure
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cellulitis
Interventions: Dermatology consult; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 246 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Community Reinforcement And Family Training, Family Health, Substance-Related Disorders
Interventions: Behavioral: Digital Tutorial Overview, Behavioral: Training Materials, Behavioral: Feedback and Coaching; Behavioral
Lead sponsor: We The Village, Inc.; Other
Eligibility: 19 Years and older
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Acute Respiratory Distress Syndrome (ARDS), Post Intensive Care Syndrome (PICS)
Interventions: An ICU admission and a temporally related ARDS diagnosis; Other
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 640,058 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Whippany, New Jersey

Conditions: Heart Failure, Heart Decompensation
Interventions: Cinaciguat (BAY58-2667), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 6
States / cities: Chicago, Illinois • Detroit, Michigan • Cincinnati, Ohio + 3 more

Conditions: Hyperglycemia
Interventions: Not listed
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Staten Island, New York

Conditions: Metabolism Requirement, Energy Requirement, Indirect Calorimetry
Interventions: Q-NRG Metobolic Cart Device; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Stem Cell Transplant Complications
Interventions: intestinal microbiota; Diagnostic Test
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 80 Years
Enrollment: 255 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 1
States / cities: Detroit, Michigan

Search by objective public record fields.

A Trial of Thickened Feeds to Treat Gastroesophageal Reflux in Children Admitted After Choking Spell

Disseminating a Digital ACP Platform (Our Care Wishes) to Hospitalized Patients

Evaluation of Behavioral Health-Virtual Patient Navigation Team (BH-VPN)

Efficacy of the Pre-Admission Medication List (PAML) Builder Reminder Prompts

Therapeutic Rest to Delay Admission in Early Labor: A Prospective Study on Morphine Sleep

CommunityRx-Hunger

Study on COPD Corticosteroid-induced Hyperglycemia on Clinical Outcome in Patients With COPD

Protocol for Admission Toxigenic C. Difficile Surveillance

Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure

Inpatient Post Admission Cognitive Therapy (PACT) for the Prevention of Suicide Attempts

Umbilical Cord Blood Use For Admission Blood Tests of Very Low Birth Weight Preterm Neonates: A Multi-center Randomized Clinical Trial

DSUVIA in Patients With SCD VOC Present in the ED

Effects of a Hypoglycemia Protocol With Glucose Gel on Neonatal Intensive Care Unit (NICU) Admission

Study of Automated Care Pathway for Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families

A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)

Trial of the Effect of Timing of Cholecystectomy During Initial Admission for Mild Gallstone Pancreatitis

Study Assessing Impact of Dermatology Consultation for Patients Admitted With Cellulitis

Scalable Digital Delivery of Evidence-based Training for Professionals to Maximize Treatment Rates of OUD in Families

An Observational Study to Identify New Health Problems Arising After an Intensive Care Unit Admission in People With Acute Respiratory Distress Syndrome in the United States

A Phase IIb Study to Investigate the Efficacy and Tolerability of Cinaciguat (150 µg/h, 100 µg/h, 50 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF)

Pre-admission Hyperglycemia and Its Effect on Morbidity and Mortality

Longitudinal Evaluation of Energy Expenditure in ICU Patients From Admission to Discharge Using A Novel Indirect Calorimeter: LEEP-Forward Trial

Intestinal Microbiota in Stem Cell Transplant Transplant Admission